ArticleClinical kidney journal2025
The Portuguese Albuminuria Study: national insights into prevalence and risk factors.
Article in Clinical kidney journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic kidney disease (CKD) is a global health concern associated with increased cardiovascular risks. In Portugal, the high burden of CKD highlights the urgent need for early detection strategies. The primary aim of this study was to assess the presence of albuminuria in the Portuguese general population while raising awareness of CKD. Methods: An epidemiological, cross-sectional study screened 601 individuals for albuminuria using urine test strips, employing a door-to-door approach across the five regions of mainland Portugal (screening study), with 592 valid results included in the final analysis. In parallel, an awareness campaign distributed 17 000 urine test strips, with 704 participants submitting their results through an online platform (awareness study). Results: The screening occurred in a healthy population, with >70% (screening study) and >87% (awareness study) of the individuals reporting no known personal health history. The presence of albuminuria was detected in 5.1% of the screening study population and 3.4% of the awareness study participants. In both studies, significant associations were found between albuminuria and risk factors, such as age, education level, CKD and non-steroidal anti-inflammatory drug use. Regional disparities were also observed. In the screening study, multivariate analysis identified education level ( Conclusions: These findings highlight albuminuria as a critical early marker for CKD and cardiovascular risks. The results support the need for targeted screening and public health initiatives, particularly in high-risk and younger populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.